series-a
Stage
2020
Founded
1
Investors
About
Kimialys develops and sells proprietary surface chemistry for biosensors, enabling high-sensitivity, rapid, and cost-effective diagnostic tests. The company specializes in K-One technology, a self-assembled monolayer optimized for gold nanoparticles and chips, enhancing biosensing applications.
Explore Kimialys's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.